The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study
Abstract
The relationship among insulin resistance, adiponectin, and cardiovascular (CV) morbidity in patients with mild and moderate kidney disease was investigated. Insulin sensitivity (Homeostasis Model Assessment of Insulin Resistance [HOMA-IR]) and adiponectin plasma levels were assessed in 227 nondiabetic renal patients at different degrees of renal dysfunction and in 76 healthy subjects of similar age and gender distribution and body mass index. In renal patients, association with prevalent CV events was evaluated, and incident CV events were evaluated in a prospective study. HOMA-IR was markedly higher in patients than in healthy subjects (3.59 +/- 3.55 versus 1.39 +/- 0.51; P < 0.01). In renal patients, HOMA-IR was significantly correlated with body mass index (r = 0.477; P < 0.01), triglycerides (r = 0.384; P < 0.01), adiponectin plasma levels (r = -0.253; P < 0.01), and age (r = 0.164; P < 0.05), but not with renal function (GFR by iod-thalamate clearance). Patients with previous CV events were significantly older, had higher HOMA-IR and serum triglycerides, and had lower adiponectin plasma levels (all P < 0.05). Logistic regression analysis revealed age (P < 0.001) and adiponectin (P < 0.002) as independent variables related to prevalent CV events. In the prospective study, median follow-up was 54 mo. Patients who experienced CV events had significantly higher serum glucose and lower adiponectin plasma levels (both P < 0.05). In patients with chronic kidney diseases, a syndrome of insulin resistance is present even in the earliest stage of renal dysfunction, and several components of this syndrome are associated with CV events. Moreover, hypoadiponectinemia is a novel putative CV risk factor in patients with mild and moderate renal failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F. A., Cutrupi, S., Parlongo, S., Malatino, L. S., Bonanno, G., Seminara, G., Rapisarda, F., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131134 · Cited by 761
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Hanley, A. J. G., Williams, K., Stern, M. P., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1177 · Cited by 637
DeFronzo, R. A., Alvestrand, A., Smith, D., Hendler, R., Hendler, E., & Wahren, J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110067 · Cited by 580
The Metabolic Syndrome: More Than the Sum of Its Parts?
Reilly, M. P., & Rader, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000088846.10655.e0 · Cited by 465
Insulin Resistance and Risk of Chronic Kidney Disease in Nondiabetic US Adults
Chen, J., Muntner, P., Hamm, L. L., Fonseca, V., Batuman, V., Whelton, P. K., & He, J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000046029.53933.09 · Cited by 396
Shinohara, K., Shoji, T., Emoto, M., Tahara, H., Koyama, H., Ishimura, E., Miki, T., Tabata, T., & Nishizawa, Y. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019900.87535.43 · Cited by 377
Asia Pacific Cohort Studies Collaboration (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh163 · Cited by 375
Hypoadiponectinemia Is Associated with Impaired Endothelium-Dependent Vasodilation
Tan, K. C. B., Xu, A., Chow, W. S., Lam, M. C. W., Ai, V. H. G., Tam, S. C. F., & Lam, K. S. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031012 · Cited by 360
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
Fliser, D., Pacini, G., Engelleiter, R., Kautzky-Willer, A., Prager, R., Franek, E., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00898.x · Cited by 359
Self-citationNew Risk Factors for Atherosclerosis and Patient Risk Assessment
Fruchart, J.-C., Nierman, M. C., Stroes, E. S. G., Kastelein, J. J. P., & Duriez, P. (2004) · Circulation · doi:10.1161/01.cir.0000131513.33892.5b · Cited by 348
Stumvoll, M., Chintalapudi, U., Perriello, G., Welle, S., Gutierrez, O., & Gerich, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118314 · Cited by 279
Wirthensohn, G., & Guder, W. G. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.2.469 · Cited by 248
Renal Pathology in Fabry Disease
Alroy, J., Sabnis, S., & Kopp, J. B. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016684.07368.75 · Cited by 243
Stenvinkel, P., Marchlewska, A., Pecoits-Filho, R., Heimbürger, O., Zhang, Z., Hoff, C., Holmes, C., Axelsson, J., Arvidsson, S., Schalling, M., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00370.x · Cited by 183
Old antihypertensives and new diabetes
Opie, L. H., & Schall, R. (2004) · Journal of Hypertension · doi:10.1097/01.hjh.0000133732.24501.9e · Cited by 168
Renal substrate exchange and gluconeogenesis in normal postabsorptive humans
Meyer, C., Stumvoll, M., Dostou, J., Welle, S., Haymond, M., & Gerich, J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2001 · Cited by 163
Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.
Gaspari, F., Perico, N., Matalone, M., Signorini, O., Azzollini, N., Mister, M., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v92310 · Cited by 161
Zoccali, C., Mallamaci, F., Panuccio, V. A., Tripepi, G. L., Cutrupi, S., Parlongo, S., Catalano, F., Tanaka, S., Ouchi, N., Kihara, S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.49.x · Cited by 128
Thomas, G. N., Chook, P., Qiao, M., Huang, X. S., Leong, H. C., Celermajer, D. S., & Woo, K. S. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118015.26978.07 · Cited by 118
Insulin regulation of renal glucose metabolism in humans
Cersósimo, E., Garlick, P. J., & Ferretti, J. A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e78 · Cited by 117
Eidemak, I., Feldt‐Rasmussen, B., Kanstrup, I., Nielsen, S. L., Schmitz, O., & Strandgaard, S. (1995) · Diabetologia · doi:10.1007/bf00400725 · Cited by 97
Intravenous calcitriol normalizes insulin sensitivity in uremic patients
Kautzky‐Willer, A., Pacini, G., Barnas, U., Ludvik, B. H., Streli, C., Graf, H., & Prager, R. (1995) · Kidney International · doi:10.1038/ki.1995.24 · Cited by 92
Kronenberg, F., Kuen, E., Ritz, E., Diaeresis]nig, P. K., Kraatz, G. D., Lhotta, K., Mann, J. F. E., Muller, G. A., Neyer, U., Riegel, W., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132461 · Cited by 88
Self-citationCarbohydrate and insulin metabolism in renal failure.
Alvestrand, A. (1997) · PubMed · Cited by 83
Insulin resistance in adult polycystic kidney disease
Vareesangthip, K., Tong, P. C. Y., Wilkinson, R., & Thomas, T. H. (1997) · Kidney International · doi:10.1038/ki.1997.360 · Cited by 80
Cardiovascular risk in patients with mild renal insufficiency
Mann, J. F. E., Gerstein, H. C., Dulau-Florea, I., & Lonn, E. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.27.x · Cited by 80
Nonhepatic glucose production in humans
Battezzati, A., Caumo, A., Martino, F. K., Sereni, L. P., Coppa, J. C., Romito, R., Ammatuna, M., Regalia, E., Matthews, D. E., Mazzaferro, V., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00486.2002 · Cited by 79
Renal hemodynamics and sodium handling in moderate renal insufficiency
Stenvinkel, P., Ottosson-Seeberger, A., & Alvestrand, A. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5101751 · Cited by 36
Altered Temporal Organization of Plasma Insulin Oscillations in Chronic Renal Failure
Feneberg, R., Sparber, M., Veldhuis, J. D., Mehls, O., Ritz, E., & Schaefer, F. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.1965 · Cited by 31
Self-citationIncreased genetic risk of hypertension in glomerulonephritis?
Schmid, M., MEYER, S. R., Wegner, R., & Ritz, E. (1990) · Journal of Hypertension · doi:10.1097/00004872-199006000-00011 · Cited by 27
Self-citation
Cited by
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Adiponectin regulates albuminuria and podocyte function in mice
Sharma, K., RamachandraRao, S., Qiu, G., Usui, H. K., Zhu, Y., Dunn, S. R., Ouedraogo, R., Hough, K., McCue, P., Chan, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32691 · Cited by 612
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Wahba, I. M., & Mak, R. H. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04071206 · Cited by 513
Insulin resistance in chronic kidney disease: a systematic review
Spoto, B., Pisano, A., & Zoccali, C. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00340.2016 · Cited by 450
Weinberg, J. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001834 · Cited by 371
Metadata
- Authors
- Becker, B., Kronenberg, F., Kielstein, J. T., Haller, H., Morath, C., Ritz, E., & Fliser, D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-04
- Volume
- 16
- Issue
- 4
- Pages
- 1091-1098
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2141458792
- Cited by
- 329
- References
- 36
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.